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Articles

Socioeconomic status and risk of cardiovascular disease in
20 low-income, middle-income, and high-income countries:
the Prospective Urban Rural Epidemiologic (PURE) study
Annika Rosengren, Andrew Smyth, Sumathy Rangarajan, Chinthanie Ramasundarahettige, Shrikant I Bangdiwala, Khalid F AlHabib,
Alvaro Avezum, Kristina Bengtsson Boström, Jephat Chifamba, Sadi Gulec, Rajeev Gupta, Ehi U Igumbor, Romaina Iqbal, Norhassim Ismail,
Philip Joseph, Manmeet Kaur, Rasha Khatib, Iolanthé M Kruger, Pablo Lamelas, Fernando Lanas, Scott A Lear, Wei Li, Chuangshi Wang,
Deren Quiang, Yang Wang, Patricio Lopez-Jaramillo, Noushin Mohammadifard, Viswanathan Mohan, Prem K Mony, Paul Poirier,
Sarojiniamma Srilatha, Andrzej Szuba, Koon Teo, Andreas Wielgosz, Karen E Yeates, Khalid Yusoff, Rita Yusuf, Afzalhusein H Yusufali,
Marjan W Attaei, Martin McKee, Salim Yusuf

Summary

Background Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence
and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease
and common measures of socioeconomic status—wealth and education—differ among high-income, middle-income,
and low-income countries, and, if so, why these differences exist. We explored the association between education and
household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of
outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel
differences in risk factor levels or differences in management.
Methods In this large-scale prospective cohort study, we recruited adults aged between 35 years and 70 years from
367 urban and 302 rural communities in 20 countries. We collected data on families and households in
two questionnaires, and data on cardiovascular risk factors in a third questionnaire, which was supplemented with
physical examination. We assessed socioeconomic status using education and a household wealth index. Education
was categorised as no or primary school education only, secondary school education, or higher education, defined as
completion of trade school, college, or university. Household wealth, calculated at the household level and with
household data, was defined by an index on the basis of ownership of assets and housing characteristics. Primary
outcomes were major cardiovascular disease (a composite of cardiovascular deaths, strokes, myocardial infarction,
and heart failure), cardiovascular mortality, and all-cause mortality. Information on specific events was obtained from
participants or their family.
Findings Recruitment to the study began on Jan 12, 2001, with most participants enrolled between Jan 6, 2005, and
Dec 4, 2014. 160 299 (87·9%) of 182 375 participants with baseline data had available follow-up event data and were
eligible for inclusion. After exclusion of 6130 (3·8%) participants without complete baseline or follow-up data,
154 169 individuals remained for analysis, from five low-income, 11 middle-income, and four high-income
countries. Participants were followed-up for a mean of 7·5 years. Major cardiovascular events were more common
among those with low levels of education in all types of country studied, but much more so in low-income
countries. After adjustment for wealth and other factors, the HR (low level of education vs high level of education)
was 1·23 (95% CI 0·96–1·58) for high-income countries, 1·59 (1·42–1·78) in middle-income countries, and 2·23
(1·79–2·77) in low-income countries (pinteraction<0·0001). We observed similar results for all-cause mortality, with
HRs of 1·50 (1·14–1·98) for high-income countries, 1·80 (1·58–2·06) in middle-income countries, and 2·76
(2·29–3·31) in low-income countries (pinteraction<0·0001). By contrast, we found no or weak associations between
wealth and these two outcomes. Differences in outcomes between educational groups were not explained by
differences in risk factors, which decreased as the level of education increased in high-income countries, but
increased as the level of education increased in low-income countries (pinteraction<0·0001). Medical care (eg,
management of hypertension, diabetes, and secondary prevention) seemed to play an important part in adverse
cardiovascular disease outcomes because such care is likely to be poorer in people with the lowest levels of
education compared to those with higher levels of education in low-income countries; however, we observed less
marked differences in care based on level of education in middle-income countries and no or minor differences in
high-income countries.
Interpretation Although people with a lower level of education in low-income and middle-income countries have
higher incidence of and mortality from cardiovascular disease, they have better overall risk factor profiles. However,
these individuals have markedly poorer health care. Policies to reduce health inequities globally must include
strategies to overcome barriers to care, especially for those with lower levels of education.
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Introduction
In high-income countries, low socioeconomic status is
associated with an increased risk of cardiovascular
disease and mortality.1–3 Whether this association also
applies to low-income and middle-income countries,
which have the highest burden of cardiovascular
disease,4,5 has been less well studied, and findings on the
association between socioeconomic status and cardio
vascular health have been inconsistent.6,7 Clarifying the
nature of the association between socioeconomic status
and cardiovascular disease in low-income and middleincome countries, and understanding the under
lying
reasons or related factors, is necessary for the develop
ment of contextually appropriate strategies to mitigate
health disparities. However, socioeconomic status is a
multidimensional construct8 related to both adequacy of
financial resources and educational attain
ment.
Therefore, the meaning and effects of socioeconomic

status on cardiovascular disease might vary according to
context, indicating the need for research in different
settings. Specifically, with rapid urbanisation and societal
change in low-income and middle-income countries, as
well as increasing rates of cardiovascular disease, there is
a need for up-to-date studies that can capture the current
situation. Although some data exist on socioeconomic
gradients in cardiovascular disease in low-income and
middle-income countries,9–14 to our knowledge no study
has used consistent methods to compare cardiovascular
disease or death by socioeconomic status, nor has any
study explored potential reasons for any observed
differences. Furthermore, to our knowledge, existing
studies have not used consistent methods or studied a
large number of countries at different levels of economic
development.
The Prospective Urban Rural Epidemiologic (PURE)
study is a large-scale prospective cohort study that

Research in context
Evidence before this study
We searched PubMed for articles published up to Feb 13, 2018,
with the search terms (MESH and All Fields) “socioeconomic
status”, “cardiovascular disease”, and “epidemiologic,
comparison” and no language limits and identified
266 abstracts; after addition of the term “management” another
42 abstracts were returned. Furthermore, we used the
Journal/Author Name Estimator search engine on the abstract of
this manuscript to identify similar publications and found
another 20 abstracts. Two authors (KBB, AR) searched all
abstracts for cross-sectional and cohort studies that compared
cardiovascular morbidity and mortality between countries of
different socioeconomic levels (high-income, middle-income,
and low-income countries) and between urban and rural
communities. Altogether, we identified 49 relevant abstracts.
We found several studies in high-income countries, but only
altogether eight in other countries, that addressed disparities in
socioeconomic position and cardiovascular complications and
made comparisons between urban and rural areas. However, we
found no studies that compared countries of high-income,
low-income, and middle-income socioeconomic status in these
respects. Therefore, although some data on socioeconomic
gradients in cardiovascular disease in low-income and
middle-income countries exist, we did not identify any that used
consistent methods or compared findings across several
countries at different levels of economic development.
Added value of this study
In high-income countries, low socioeconomic status is
associated with an increased risk of cardiovascular disease.

Whether this association also applies in low-income and
middle-income countries, which have the largest burden of
cardiovascular disease, has been less well studied and the
results of existing studies are inconsistent. We found that low
education was a stronger marker for cardiovascular disease
and mortality than was wealth. This association was most
marked in low-income countries (mainly India, Pakistan, and
Bangladesh), less marked in middle-income countries, and
least evident in high-income countries (mainly Canada and
Sweden). Differences in risk factor proportions, which to a
large extent were lower in individuals living in low-income
countries, did not explain the different risks of cardiovascular
disease in different educational groups. By contrast, less
educated individuals in low-income countries received fewer
medications for hypertension, diabetes, or secondary
prevention and were less likely to quit smoking or have a
healthy diet.
Implications of all the available evidence
Education, rather than wealth, was the factor most strongly
associated with the study primary outcomes, with low
education being associated with an increased risk of major
cardiovascular disease and higher case fatality, despite lower
proportions of cardiovascular risk factors in low-income
countries than in high-income countries. Improved education
and access to effective health care might mitigate some of the
substantial excess burden of cardiovascular disease and
mortality in low-income countries and narrow global health
inequalities.
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Total patients

Education
None or primary only

Secondary

Trade school, college, or
university

High-income countries
Total number of people
Age (years)

17 241 (100·0%)
52·2 (9·4)

2137 (12·4%)
55·1 (9·7)

4995 (29·0%)
52·4 (9·3)

10 109 (58·6%)
51·5 (9·3)

Sex
Women

9241 (53·6%)

1289 (60·3%)

2739 (54·8%)

5213 (51·6%)

Men

8000 (46·4%)

848 (39·7%)

2256 (45·2%)

4896 (48·4%)

Urban

13 320 (77·3%)

1351 (63·2%)

3584 (71·8%)

8385 (82·9%)

2307 (13·4%)

321 (15·0%)

896 (17·9%)

1090 (10·8%)

INTERHEART risk score

13·08 (6·1)

13·95 (6·2)

13·79 (6·3)

12·54 (5·9)

INTERHEART risk score without smoking

11·41 (5·4)

12·28 (5·6)

11·68 (5·5)

Current use of at least one tobacco product per day

2051/4836 (42·4%)

11·09 (5·3)

Hypertension*

6594/16 647 (39·6%)

1101/1915 (57·5%)

3442/9896 (34·8%)

Diabetes, self-reported or on glucose-lowering agent
(known diabetes)†

1609 (9·3%)

484 (22·6%)

458 (9·2%)

667 (6·6%)

Diabetes, self-reported or fasting glycaemia
≥7 mmol/L or no-fasting glucose >7·7 mmol/L

1867 (10·8%)

536 (25·1%)

544 (10·9%)

787 (7·8%)

Cardiovascular disease‡

1345 (7·8%)

246 (11·5%)

399 (8·0%)

700 (6·9%)

Middle-income countries
Total number of people
Age (years)

102 843 (100·0%)
51·0 (9·6)

45 820 (44·6%)
53·4 (9·6)

41 862 (40·7%)
48·7 (8·9)

15 161 (14·7%)
49·9 (9·8)

Sex
Women

60 397 (58·7%)

29 152 (63·6%)

23 564 (56·3%)

7681 (50·7%)

Men

42 446 (41·3%)

16 668 (36·4%)

18 298 (43·7%)

7480 (49·3%)

Urban

53 206 (51·7%)

15 920 (34·7%)

24 030 (57·4%)

13 256 (87·4%)

Current use of at least one tobacco product per day

21 610 (21·0%)

8955 (19·5%)

9816 (23·4%)

2839 (18·7%)

10·52 (5·8)

10·99 (5·8)

9·88 (5·6)

10·91 (5·9)

8·62 (5·1)

9·21 (5·2)

7·81 (4·9)

INTERHEART risk score
INTERHEART risk score without smoking
Hypertension*
Diabetes, self-reported or on glucose-lowering agent
(known diabetes)†
Diabetes, self-reported or fasting glycaemia
≥7 mmol/L or no-fasting glucose >7·7 mmol/L
Cardiovascular disease‡

41 932/96 628 (43·4%)

21 019/43 350 (48·5%)

15 234/38 701 (39·4%)

9·05 (5·2)
5679/14 577 (39·0%)

8229 (8·0%)

4234 (9·2%)

2721 (6·5%)

1274 (8·4%)

10 709 (10·4%)

5354 (11·7%)

3753 (9·0%)

1602 (10·6%)

8950 (8·7%)

4488 (9·8%)

2922 (7·0%)

1540 (10·2%)

34 085 (100·0%)

18 095 (53·1%)

11 653 (34·2%)

4337 (12·7%)

Low-income countries
Total number of people
Age (years)

48·6 (10·3)

49·3 (10·7)

47·8 (9·8)

47·9 (9·9)

Sex
Women

19 446 (57·1%)

11 925 (65·9%)

5856 (50·3%)

1665 (38·4%)

Men

14 639 (42·9%)

6170 (34·1%)

5797 (49·7%)

2672 (61·6%)

Urban

15 514 (45·5%)

5096 (28·2%)

6680 (57·3%)

3738 (86·2%)

7755 (22·8%)

5027 (27·8%)

2237 (19·2%)

491 (11·3%)

INTERHEART risk score

7·86 (5·0)

6·98 (4·6)

8·77 (5·3)

9·12 (5·4)

INTERHEART risk score without smoking

6·95 (4·8)

6·00 (4·4)

7·83 (5·0)

Current use of at least one tobacco product per day

Hypertension*

10 122/31 233 (32·4%)

4598/16 085 (28·6%)

3906/11 017 (35·5%)

8·52 (5·1)
1618/4131 (39·2%)

Diabetes, self-reported or on glucose-lowering agent
(known diabetes)†

3195 (9·4%)

1007 (5·6%)

1536 (13·2%)

652 (15·0%)

Diabetes, self-reported or fasting glycaemia
≥7 mmol/L or no-fasting glucose >7·7 mmol/L

4343 (12·7%)

1474 (8·1%)

2040 (17·5%)

829 (19·1%)

Cardiovascular disease‡

1530 (4·5%)

760 (4·2%)

583 (5·0%)

187 (4·3%)

Data are n (%), mean (SD), or n/N (%). *Self-reported or on medications, or blood pressure ≥140/≥90 mm Hg. †Plasma glucose concentrations were available in 122 711 participants. ‡Diagnosed with stroke,
coronary heart disease, heart failure, or other heart disease before baseline visit.

Table 1: Participant characteristics stratified by education in high-income, middle-income, and low-income countries
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participants with INTERHEART risk score >10 (%)

Articles

100

pinteraction <0·0001*
ptrend <0·0001

80
66·9 67·5
60

60·7

ptrend 0·357
50·0

44·9

49·6

Education
None or primary only
Secondary
Trade school, college,
or university
ptrend <0·0001
34·7 35·9

40
21·6
20

0

High-income
countries

Middle-income
countries

Low-income
countries

Figure 1: Age-standardised and sex-standardised proportion of participants
with INTERHEART risk score >10 in high-income, middle-income, and
low-income countries by education
Data are adjusted for age and gender. *Testing the interaction between country
income and education.

recruited individuals from high-income, low-income,
and middle-income countries, providing an opportunity
to explore associations between socioeconomic status
and cardiovascular disease across settings at varying
economic levels. In this Article, we describe the
association between two markers of socioeconomic
status (education and household wealth) and cardio
vascular disease and mortality to assess which marker is
the stronger predictor of outcomes. We also examined
whether any differences in cardiovascular disease by
socioeconomic status paralleled differences in risk factor
levels or differences in management (using markers of
health care such as hypertension control, diabetes care,
and use of secondary prevention strategies).

Methods

Study design and participants

See Online for appendix
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The design, methods (including sampling, information
gathered, and follow-up strategy), and participant
characteristics of the PURE study have been published
previously.15 Briefly, adults aged between 35 years and
70 years from 367 urban and 302 rural communities in
20 countries (Tanzania, Zimbabwe, Bangladesh, Pakistan,
India, occupied Palestinian territory, China, Colombia,
Iran, South Africa, Malaysia, Argentina, Turkey, Brazil,
Poland, Chile, Saudi Arabia, United Arab Emirates,
Canada, and Sweden) were included. Details of sampling,
information gathered, and follow-up strategy have been
previously reported in several publications.15,16
For the present study, follow-up event data were
available until Sept 20, 2017. The countries were grouped
according to the 2006 World Bank income classifications17
based on gross national product per capita at the time
when data collection began (appendix). Men and women
aged between 35 years and 70 years, who were expected to
remain in their community for at least 4 years, were
eligible for inclusion. The response rate was 72%.

Although modest differences exist between the PURE
household population and national data, these differences
are unlikely to have much of an effect on the exposure–
disease associations derived in PURE, and demographics
and mortality were generally similar to national statistics.18
Ethics committees at each centre approved the protocol
and all participants provided written informed consent.

Procedures
We collected data on families and households in two
questionnaires, the first recording sociodemographic
information on all inhabitants of the household and the
second recording information on house structure and
amenities. Data on cardiovascular risk factors (tobacco
use, history of hypertension, diabetes, psychosocial fac
tors, diet, physical activity, and physical measures) were
recorded using standardised questions and methods in a
third questionnaire, which was supplemented by physical
examination, including blood pressure, anthropometric
measures, spirometry, and an electrocardiogram. Further
questionnaires assessed diet (food frequency) and
physical activity by use of standardised instruments.
Consenting participants also provided a fasting blood
sample (appendix). The non-cholesterol INTERHEART
risk score,19 which integrates information on age, sex,
smoking, diabetes (self-report or fasting glucose
>7·0 mmol/L), high blood pressure (blood pressure
>140/>90 mm Hg or self-report), family history of heart
disease, waist to hip ratio, psychosocial factors, diet
(healthy eating score), and physical activity, was used to
describe overall risk factor levels (appendix).15,16 The
quality of data collection was maintained by the use of
standardised protocols, centralised training, and stringent
quality control at the project office.
We assessed socioeconomic status using education and
a household wealth index. Education was categorised as
no or primary school education only (lowest), secondary
school education (intermediate), or higher education,
defined as completion of trade school, college, or
university (highest). Household wealth, calculated at the
household level and with household data, was defined by
an index on the basis of ownership of assets and housing
characteristics,20 validated in several countries, and
documented to be a robust measure of wealth, consistent
with measures of income and expenditure.

Outcomes
Primary outcomes were major cardiovascular disease (a
composite of cardiovascular deaths, strokes, myocardial
infarction, and heart failure; appendix), cardiovascular
mortality, and all-cause mortality.
Information on specific events was obtained from
participants or their family, who were contacted at regular
intervals after the questionnaires were delivered. Followup of participants was done at 3-year intervals and
information on clinical events was obtained from
participants or family members for deceased participants.
www.thelancet.com/lancetgh Vol 7 June 2019
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High-income countries

Middle-income countries

Low-income countries

Number of
events

Age-standardised and
sex-standardised
event rate per
1000 person-years
(95% CI)

Number of
events

Age-standardised and
sex-standardised event
rate per
1000 person-years
(95% CI)

Number of
events

Age-standardised and
sex-standardised
event rate per
1000 person-years
(95% CI)

None or primary only

101

5·3 (4·2–6·4)

2683

8·1 (7·7–8·4)

2149

16·0 (15·0–17·0)

Secondary

116

2·9 (2·3–3·4)

1140

4·7 (4·4–5·0)

872

10·8 (10·0–12·0)

Trade school, college, or
university

199

2·6 (2·2–3·0)

332

3·2 (2·9–3·6)

152

5·3 (4·2–6·5)

All-cause mortality
By education

By wealth
Poorest third

168

3·8 (3·2–4·4)

1807

8·1 (7·7–8·5)

1471

16·4 (16·0–17·0)

Middle third

116

2·5 (2·0–3·0)

1327

5·6 (5·2–5·9)

974

13·7 (13·0–15·0)

Richest third

132

3·0 (2·4–3·6)

1021

4·6 (4·3–4·9)

728

8·7 (8·0–9·4)

Cardiovascular mortality
By education
None or primary only

25

1·3 (0·8–1·8)

841

2·4 (2·2–2·6)

627

4·6 (4·3–5·0)

Secondary

21

0·6 (0·3–0·8)

304

1·3 (1·1–1·5)

320

3·9 (3·4–4·4)

Trade school, college, or
university

36

0·4 (0·3–0·6)

98

1·0 (0·8–1·2)

52

1·6 (1·1–2·2)

By wealth
Poorest third

41

1·0 (0·7–1·3)

566

2·5 (2·3–2·8)

366

4·1 (3·7–4·6)

Middle third

14

0·3 (0·1–0·4)

394

1·6 (1·4–1·7)

348

4·9 (4·4–5·5)

Richest third

27

0·6 (0·3–0·9)

283

1·3 (1·1–1·5)

285

3·3 (2·9–3·7)

7·5 (7·0–8·0)

Major cardiovascular disease
By education
None or primary only

127

7·3 (5·7–8·9)

2551

7·3 (6·9–7·6)

1038

Secondary

171

4·5 (3·8–5·3)

1493

5·8 (5·4–6·1)

645

7·7 (7·0–8·4)

Trade school, college, or
university

293

3·7 (3·2–4·2)

506

4·9 (4·5–5·4)

112

3·5 (2·7–4·3)

Poorest third

228

5·5 (4·7–6·3)

1748

7·4 (7·0–7·7)

587

6·3 (5·8–6·8)

Middle third

161

3·2 (2·6–3·7)

1506

6·1 (5·8–6·5)

614

8·5 (7·8–9·2)

Richest third

202

4·8 (4·0–5·5)

1296

5·6 (5·2–5·9)

594

6·9 (6·3–7·5)

By wealth

For standardisation, the 2015 UN population data was used as the reference.

Table 2: Age-standardised and sex-standardised event rates per 1000 person-years by education and by country income

All follow-up visits were done either by visiting
households or by telephone calls from participants, or, in
countries such as Canada, the participants were invited
to the central office to complete the follow-up visit. Events
were adjudicated centrally in each country by trained
physicians by use of standardised definitions, verbal
autopsies, and review of documents.16

Statistical analysis
We used direct standardisation to calculate the agestandardised and sex-standardised incidence rates
(per 1000 person-years) for cardiovascular events and
deaths. We used multi-level Cox proportional hazard
models to obtain the hazard ratios (HRs) for all-cause
mortality, fatal cardiovascular disease, and major
cardiovascular disease. In the multi-level structure
models, we considered individual participants nested in
www.thelancet.com/lancetgh Vol 7 June 2019

For UN population data see
https://population.un.org/wpp/
DataQuery/

centres and considered centres as a random intercept
effect. We mutually adjusted HRs for education and
wealth, in addition to age, sex, urban versus rural,
baseline cardiovascular disease, and INTERHEART risk
score. We included the interaction terms of region and
education and region and wealth, where region denoted
high-income, middle-income, or low-income countries.
We tested the assumption of proportional hazard with
log of the negative log of Kaplan-Meier estimates of the
survival function versus the log time for evidence of nonparallelism.
Defining countries according to country income might
not adequately capture inequalities across the entire
distribution of education or wealth. Consequently, we
also used the Wagstaff index, which has been proposed
as an alternative to the concentration index when the
health variable is bounded (ie, has an upper and lower
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All-cause mortality
Events/total

pinteraction value

Adjusted HR (95% CI)

pinteraction value*

Major cardiovascular disease
Events/total

Adjusted HR (95% CI)

Association of events by education
High-income countries
None or primary only

101/2135

1·50 (1·14–1·98)

127/2135

1·23 (0·96–1·58)

Secondary

116/4985

0·99 (0·78–1·25)

171/4985

1·01 (0·83–1·22)

Trade school, college, or university

199/10 065

1·00 (ref)

293/10 065

1·00 (ref)

<0·0001

0·1079

0·0149

ptrend

<0·0001

Middle-income countries
None or primary only

2682/45 110

1·80 (1·58–2·06)

2549/45 110

1·59 (1·42–1·78)

Secondary

1134/41 135

1·37 (1·20–1·56)

1490/41 135

1·29 (1·16–1·43)

Trade school, college, or university

331/14 967

1·00 (ref)

505/14 967

<0·0001

ptrend

1·00 (ref)
<0·0001

Low-income countries
2145/16 472

2·76 (2·29–3·31)

1034/16 472

2·23 (1·79–2·77)

Secondary

872/10 975

2·02 (1·69–2·42)

645/10 975

2·01 (1·63–2·48)

Trade school, college, or university

152/3974

1·00 (ref)

112/3974

None or primary only

<0·0001

ptrend

1·00 (ref)
<0·0001

Association of events by wealth
High-income countries
Poorest third

168/4747

1·15 (0·91–1·46)

228/4747

1·11 (0·91–1·35)

Middle third

116/6213

0·84 (0·66–1·08)

161/6213

0·81 (0·66–1·00)

Richest third

132/6225

1·00 (ref)

202/6225

1·00 (ref)

0·0119

0·1279

ptrend

0·0021

0·4193

Middle-income countries
Poorest third

1805/33 071

1·27 (1·16–1·39)

1745/33 071

1·07 (0·98–1·17)

Middle third

1324/33 829

1·06 (0·97–1·15)

1505/33 829

0·99 (0·92–1·07)

Richest third

1018/34 312

1·00 (ref)

1294/34 312

1·00 (ref)

<0·0001

ptrend

0·0486

Low-income countries
Poorest third

1470/10 388

1·46 (1·29–1·65)

586/10 388

1·10 (0·95–1·28)

Middle third

973/9945

1·30 (1·17–1·45)

613/9945

1·18 (1·04–1·33)

Richest third

726/11 088

1·00 (ref)

592/11 088

1·00 (ref)

ptrend

<0·0001

0·3534
0

0·5

1

1·5

2

2·5

3

3·5

0

0·5

1

1·5

2

2·5

Figure 2: HRs (95% CI) for all-cause mortality and major cardiovascular disease by country income and level of education
We included the interaction terms region and education, as well as region and wealth, where region denoted high-income, middle-income, or low-income countries. HR=hazard ratio. *Testing the
interaction between country income and education or wealth.

limit).21,22 The Wagstaff index is the concentration index
divided by 1 minus the mean of the health variable,
producing a value between –1 and 1.
We calculated case fatality rates in the 28 days following
myocardial infarction, stroke, and heart failure adjusted
for age and sex. We calculated age-adjusted and sexadjusted case fatality rates by education or wealth and
stratified by country income with the method of least
squares to fit general linear models. Reported ptrend values
on the figures are for case fatality rates within each
country income grouping using the χ² test for trend.
Given the multiple comparisons, p values should be
interpreted with caution, unless very small (eg, p<0·0001).
All analyses were done with SAS version 9.4 and all
figures were drawn in R version 3.2.5.

Role of the funding source
The funders and sponsors of the study had no role in
the study design and conduct, data collection, data
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analysis, data interpretation, writing of the report, or the
decision to submit the manuscript for publication. The
corresponding author had full access to all the data in
the study and had final responsibility for the decision to
submit for publication.

Results
Recruitment to the study began on Jan 12, 2001, with
most participants enrolled between Jan 6, 2005, and
Dec 4, 2014. 160 299 (87·9%) of 182 375 participants
with baseline data had available follow-up event data,
and were aged between 35 and 70 years and from
20 countries (other countries and participants were
enrolled too recently to have had a follow-up visit).
After exclusion of 6130 (3·8%) partici
pants without
complete baseline or follow-up data, 154 169 remained
for analysis (appendix). Populations had diverse sizes,
with India contributing 81% of the low-income
population, and China 45% of the middle-income
www.thelancet.com/lancetgh Vol 7 June 2019
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A

Mortality rate

Tanzania
Zimbabwe
Bangladesh
Pakistan
India
Occupied Palestinian territory
China

Increasing GDP

Colombia
Iran
South Africa
Malaysia
Argentina
Turkey
Brazil
Poland
Chile
Saudi Arabia
Education
None or primary school
Secondary
Trade school, college, or university

United Arab Emirates
Canada
Sweden

B

Cardiovascular disease

Tanzania
Zimbabwe
Bangladesh
Pakistan
India
Occupied Palestinian territory
China
Colombia
Increasing GDP

population, whereas Canada contributed 60% of the
high-income population.
4337 (12·7%) of 34 085 participants from low-income
countries had a university, college, or trade school edu
cation, compared with 15 161 (14·7%) of 102 843 participants
in middle-income countries and 10 109 (58·6%) of
17 241 participants in high-income countries (table 1).
Corresponding proportions for primary education or
less were 18 095 (53·1%) for low-income countries,
45 820 (44·6%) in middle-income countries, and
2137 (12·4%) in high-income countries. Across all coun
tries, participants with a high level of education were
younger, and less likely to be women. In high-income
countries, individuals with a low level of education had
higher INTERHEART risk scores than did those with
higher levels of education, and more frequently had
hypertension, diabetes, and previous cardiovascular
disease, whereas the opposite was true for low-income
countries, with the exception of previous cardiovascular
disease, which was similar across all education categories
(table 1). We recorded the proportion of participants with
INTERHEART risk scores score greater than 10 (figure 1).
With respect to the findings for individual countries,
India and Bangladesh, which constituted 88% of the lowincome population, both had higher INTERHEART risk
scores among people with higher levels of education,
although findings for the smaller samples in the other
three low-income countries were heterogeneous (data not
shown). Characteristics by wealth categories and
individual components of the INTERHEART risk score
by education are shown in the appendix.
Over a mean follow-up duration of 7·5 years until
Sept 20, 2017, we recorded 7744 deaths and 6936 cases of
major cardiovascular disease. Mortality varied sub
stantially by education and country income (table 2), with
the highest mortality in low-income countries and in
those with the lowest levels of education across country
income categories. The group with the lowest level
of education in low-income countries had an agestandardised and sex-standardised mortality rate of 16·0
(95% CI 15·0–17·0) per 1000 person years—more than
five times that of people with the highest level of education
in high-income countries (2·6 per 1000 person-years,
95% CI 2·2–3·0). Similar results were also seen for
cardiovascular mortality (table 2). When stratified by
household wealth, total and cardiovascular mortality rates
varied from 16·4 (95% CI 16·0–17·0) and 4·1 (3·7–4·6)
per 1000 person-years, respectively, among the poorest
third of participants in low-income countries to 3·0
(2·4–3·6) and 0·6 (0·3–0·9) per 1000 person-years,
respectively, among the richest third of participants in
high-income countries. Incidence of major cardiovascular
disease was similar for people with the lowest levels of
education across low-income, middle-income, and highincome countries (7·5 per 1000 person-years, 95% CI
7·0–8·0, in low-income countries, 7·3 per 1000 personyears, 6·9–7·6, in middle-income countries, and 7·3 per

Iran
South Africa
Malaysia
Argentina
Turkey
Brazil
Poland
Chile
Saudi Arabia
United Arab Emirates
Canada
Sweden
0

20

40

Age-standardised and sex-standardised event rate per 1000 person-years

Figure 3: Age-standardised and sex-standardised mortality (A) and cardiovascular disease incidence (B) per
1000 person-years by level of education
Data are stratified by country and arranged by increasing GDP (data for categories with fewer than eight events
not shown). GDP=gross domestic product.
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50

CFR (%)

40

Education
None or primary only
Secondary
Trade school, college,
or university
ptrend 0·0004

30
20

ptrend <0·0001

ptrend 0·5001

10
0
Case fatality rate
OR
(95% CI)

High-income countries

Middle-income countries

Low-income countries

4·32
3·55
7·13
24·22
14·77 13·61
45·27
38·98 34·05
0·66
0·53
1·00 (ref)
1·9
1·25 1·00 (ref)
2·23
1·49 1·00 (ref)
(0·2–1·9) (0·2–1·4)
(1·4–2·7) (0·9–1·8)
(1·4–3·4) (0·9–2·3)

Figure 4: 28-day CFR after a first cardiovascular event and OR by country income and level of education
among participants without previous cardiovascular disease
pinteraction<0·0001 for country income and education. We adjusted ORs for age and sex. CFR=case fatality rate.
OR=odds ratio.

1000 person-years, 5·7–8·9, in high-income countries).
The incidence rates for those with the highest level of
education were 3·5 per 1000 person-years (95% CI
2·7–4·3) in low-income countries, 4·9 per 1000 personyears (4·5–5·4) in middle income countries, and
3·7 per 1000 person-years (3·2–4·2) in high-income
countries. The association between wealth and outcomes
was weaker than the same comparisons between
education and outcomes, and this was consistently
observed among men and women (data not shown).
In multivariable models that simultaneously adjusted
for education and wealth, in addition to age, sex, urban
versus rural setting, baseline cardiovascular disease,
and INTERHEART risk score, education was a strong
independent predictor for total mortality (HR 2·76,
95% CI 2·29–3·31, in low-income countries,
1·80, 1·58–2·06, in middle-income countries, and 1·50,
1·14–1·98, in high-income countries) when comparing
the lowest level of education with the highest level of
education (pinteraction<0·0001; figure 2). We observed
similar results for major cardiovascular disease (2·23,
1·79–2·77, for low-income countries, 1·59, 1·42–1·78,
for middle-income countries, and 1·23, 0·96 to 1·58,
for high-income countries; pinteraction<0·0001). Level of
education was a far stronger predictor for major
cardiovascular disease and all-cause mortality than was
wealth. We also calculated mutually adjusted HRs by
education and wealth, stratified by countries grouped
by income, but adjusted for separate risk factors rather
than the composite INTERHEART risk score
(appendix). Sensitivity analyses from which subjects
with previous cardiovascular disease were excluded
provided similar results (appendix).
Cardiovascular event rates and death rates by individual
country ranked by their gross domestic product (GDP)
are shown in figure 3. The only low-income country with
a sufficient number of events for analysis in people with a
high level of education was India, but we observed similar
e755

patterns in the other low-income countries, for which we
were able to compare middle and low levels of education.
The Wagstaff index results reaffirmed our conclusions,
specifically that although the patterns of inequality were
broadly similar for education and the wealth index, the
strength of the association between education and out
comes was stronger than the corresponding association
between the wealth index and outcomes, as indicated by
the relatively lower index estimates for wealth (appendix).
Importantly, the index estimates were consistent with
our conclusions from figure 2 and table 2.
5509 (79·4%) of 6936 major cardiovascular disease
events recorded occurred in participants with no previous
cardiovascular disease at baseline, of whom 1407 (25·5%)
died within 28 days. We observed substantial differences
between countries at different income levels with respect
to absolute case fatality rates (CFRs), and in the
association between level of education and CFR
(pinteraction<0·0001 for country income and education;
figure 4). The gradients in CFRs between the highest and
the lowest levels of education were steepest in lowincome and middle-income countries, and we observed
no gradient in high-income countries, where there were
fewer overall fatalities. Corresponding data for wealth are
shown in the appendix.
Hypertension and diabetes are among the most
important risk factors for cardiovascular disease and
related mortality and treating them is proven to reduce
complications, as does secondary prevention in people
with known cardiovascular disease. Therefore, we exam
ined variations in the medical treatment of hypertension
and diabetes, and in secondary prevention, by education
and country income as a marker of management of these
conditions (table 3). 27 327 (46·6%) of 58 642 participants
with hypertension were aware of their condition. In the
high-income countries included in our study, medical
treatment did not vary by education, whereas we found a
consistent and significant inverse association between
level of education and treatment in low-income and
middle-income countries (pinteraction<0·0001).
13 207 (8·6%) of 153 934 participants had known
diabetes—1609 (9·3%) in high-income countries,
8224 (8·0%) in middle-income countries, and 3194 (9·4%)
in low-income countries (table 3). 1198 (74·5%) of
1609 people with known diabetes in high-income
countries used hypoglycaemic drugs, with no differences
by education, and 4349 (52·9%) of 8224 people with
known diabetes in middle-income countries used
hypoglycaemic drugs, with slightly lower use with lower
levels of education. Among those with the highest level
of education in low-income countries, 248 (38·0%) of
652 participants were on medication for their diabetes,
but only 232 (23·1%) of 1006 participants with low levels
of education also took such medication (odds ratio
[OR] 0·43, 95% CI 0·34–0·54; pinteraction<0·0001; table 3).
We also examined differences in use of secondary
prevention medications as a potential explanation of the
www.thelancet.com/lancetgh Vol 7 June 2019

924/1035 (89·3%)

Secondary
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394/484 (81·4%)

328/458 (71·6%)

476/667 (71·4%)

Proportion treated with
hypoglycaemic agents

None or primary only

Secondary

Trade school, college,
or university

229/425 (53·9%)

Trade school, college, or university

1·00 (ref)

1·05 (0·78–1·42)

0·80 (0·53–1·21)

··

··

··

0·4695

··

··

··

<0·0001

··

··

··

0·0061

··

··

··

0·0256

··

··

··

··

0·6854

··

··

··

··

0·9774

··

··

623/1467 (42·5%)

1144/2682 (42·7%)

1605/4176 (38·4%)

3372/8325 (40·5%)

668/1408 (47·4%)

1148/2545 (45·1%)

1364/4020 (33·9%)

3180/7973 (39·9%)

316/590 (53·6%)

477/1057 (45·1%)

676/1408 (48·0%)

1469/3055 (48·1%)

585/1540 (38·0%)

1084/2922 (37·1%)

1948/4488 (43·4%)

3617/8950 (40·4%)

8950/102 640 (8·7%)

696/1274 (54·6%)

1417/2719 (52·1%)

2236/4231 (52·8%)

4349/8224 (52·9%)

8224/102 640 (8·0%)

2462/2872 (85·7%)

5509/6607 (83·4%)

8828/10 520 (83·9%)

16 799/19 999 (84·0%)

19 999/41 926 (47·7%)

1·00 (ref)

1·16 (1·01–1·33)

1·11 (0·97–1·27)

··

1·00 (ref)

0·75 (0·65–0·86)

0·50 (0·43–0·58)

··

1·00 (ref)

1·03 (0·83–1·29)

0·81 (0·65–1·01)

··

1·00 (ref)

1·28 (1·10–1·48)

1·10 (0·95–1·28)

··

··

1·00 (ref)

0·94 (0·81–1·08)

0·77 (0·66–0·89)

··

··

1·00 (ref)

0·89 (0·78–1·01)

0·66 (0·58–0·75)

··

··

··

··

0·2709

··

··

··

<0·0001

··

··

··

0·0245

··

··

··

0·6632

··

··

··

<0·0001

··

··

··

··

<0·0001

··

··

181/548 (33·0%)
36/167 (21·6%)

148/477 (31·0%)

1·00 (ref)

1·34 (0·86–2·08)

1·52 (0·98–2·34)

··

1·00 (ref)
365/1192 (30·6%)

0·66 (0·44–1·01)
52/174 (29·9%)

0·36 (0·24–0·55)

··

1·00 (ref)

0·66 (0·33–1·32)

0·35 (0·17–0·72)

··

1·00 (ref)

0·76 (0·50–1·16)

0·26 (0·17–0·41)

··

··

1·00 (ref)

0·64 (0·52–0·79)

0·43 (0·34–0·54)

··

··

1·00 (ref)

0·56 (0·44–0·72)

0·28 (0·22–0·36)

··

··

121/516 (23·4%)

112/590 (19·0%)

285/1280 (22·3%)

21/45 (46·7%)

80/197 (40·6%)

57/252 (22·6%)

158/494 (32·0%)

60/187 (32·1%)

113/583 (19·4%)

67/760 (8·8%)

240/1530 (15·7%)

1530/34 058 (4·5%)

248/652 (38·0%)

446/1536 (29·0%)

232/1006 (23·1%)

926/3194 (29·0%)

3194/34 058 (9·4%)

675/797 (84·7%)

1420/1808 (78·5%)

922/1442 (63·9%)

3017/4047 (74·5)

4047/10 122 (40·0%)

··

··

0·0659

··

··

··

<0·0001

··

··

··

0·0008

··

··

··

<0·0001

··

··

··

··

<0·0001

··

··

··

··

<0·0001

··

··

ptrend

··

··

0·2941

··

··

··

0·0044

··

··

··

0·0387

··

··

··

<0·0001

··

··

··

··

<0·0001

··

··

··

··

<0·0001

··

··

p value*

Table 3: Proportions of patients with hypertension treatment, diabetes treatment, and secondary prevention treatment by education adjusted for age and sex

Participants who had missing information on history of cardiovascular disease at baseline were excluded from this analysis (235 individuals). All ORs are adjusted for age, sex, and centre as a random effect, and treatment for hypertension and
treatment for diabetes were additionally adjusted for baseline history of cardiovascular disease. OR=odds ratio. *Interaction between education and country income. †Self-reported or on medications, or blood pressure ≥140/≥90 mm Hg.
‡Self-reported diabetes or on glucose-lowering agent. §At least one of antiplatelet, β blockers, angiotensin-converting-enzyme inhibitors or angiotensin II receptor blockers, or statins. ¶Alternative Healthy Eating Index score in the third tertile.
||Metabolic equivalent score >3000.

168/305 (55·1%)

61/127 (48·0%)

458/857 (53·4%)

Secondary

None or primary only

High level of physical activity||

0·40 (0·28–0·55)

64/334 (19·2%)

173/468 (37·0%)

Secondary

Trade school, college, or university

1·00 (ref)

0·30 (0·18–0·49)

··

1·00 (ref)

0·63 (0·43–0·91)

0·57 (0·35–0·92)

··

23/160 (14·4%)

None or primary only

260/962 (27·0%)

295/381 (77·4%)

Trade school, college, or university

Healthy eating¶

82/125 (65·6%)

182/265 (68·7%)

None or primary only

559/771 (72·5%)

Secondary

Smoking cessation (among former
and current smokers)

1·06 (0·78–1·45)

525/700 (75·0%)

1·00 (ref)

308/399 (77·2%)

Secondary

Trade school, college,
or university

··
1·82 (1·14–2·89)

1040/1345 (77·3%)

··

1·00 (ref)

0·90 (0·68–1·18)

1·14 (0·80–1·62)

··

··

1·00 (ref)

0·83 (0·64–1·08)

1·15 (0·77–1·72)

··

··

207/246 (84·1%)

None or primary only

Proportion medically treated§

People with cardiovascular disease at 1345/17 236 (7·8%)
baseline

1609/17 236 (9·3%)

1198/1609 (74·5%)

People with known diabetes‡

Trade school, college, or university 1500/1658 (90·5%)

547/588 (93·0%)

2971/3281 (90·6%)

3281/6594 (49·8%)

None or primary only

Proportion treated

People with hypertension† and
aware of their condition

OR (95% CI)

n/N (%)

ptrend

Low-income countries (n=34 058)

OR (95% CI)

n/N (%)

ptrend

Middle-income countries (n=102 640)

OR (95% CI)

High-income countries (n=17 236)

n/N (%)
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high mortality among people with low levels of edu
cation in low-income and middle-income countries.
11 825 (7·7%) of 153 934 study participants had a previous
cardiovascular disease event at baseline (table 3). Use of
at least one medication was reported by 1040 (77·3%) of
1345 participants in high-income countries, 3617 (40·4%)
of 8950 participants in middle-income countries, and
240 (15·7%) of 1530 participants in low-income countries.
In high-income countries, people with low education had
higher use of any secondary prevention medication
(OR 1·82, 95% CI 1·14–2·89), whereas there was no
systematic variation in middle-income countries (OR for
lowest level vs highest level of education 1·10, 95% CI
0·95–1·28). In low-income countries, 60 (32·1%) of
187 participants with the highest level of education and
67 (8·8%) of 760 participants with no or primary
education only used any secondary preventive drug
(OR 0·26, 95% CI 0·17–0·42; pinteraction<0·0001).
Overall, quitting smoking was more common in those
with higher education in all types of country—295 (77·4%)
of 381 participants in high-income countries, 316 (53·6%)
of 590 participants in middle-income countries, and
21 (46·7%) of 45 participants in low-income countries
with trade school, college, or university level education,
compared with 82 (65·6%) of 125 participants in highincome countries, 676 (48·0%) of 1408 participants in
middle-income countries, and 57 (22·6%) of
252 participants in low-income countries with no or
primary only education (pinteraction 0·0387; table 3). A higher
healthy diet score (alternative healthy eating index;
appendix) was less common with lower levels of
education across high-income, middle-income, and lowincome countries (table 3). High levels of physical activity
were more common among those with low education in
low-income countries, but we found no significant
interaction between country income and education
(p=0·2941; table 3).

Discussion
We found that socioeconomic gradients with respect to
cardiovascular disease and mortality varied between
high-income, middle-income, and low-income countries,
with inverse gradients that were steepest in poorer
countries. Variations in traditional risk factors, as
captured by the INTERHEART risk score, did not explain
the differences in outcomes by socioeconomic status,
because risk factors were generally lower in those with
lower levels of education in low-income countries.
Education, rather than wealth, was the socioeconomic
indicator most consistently associated with outcomes,
and people with low levels of education in low-income
and middle-income countries had a markedly higher risk
of major cardiovascular events compared with those with
higher levels of education. Socioeconomic differences in
primary and secondary prevention were also pronounced,
with the least advantaged people (ie, those with low levels
of education in low-income countries) receiving very
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poor secondary prevention, and markedly poorer diabetes
and hypertension treatment compared with all other
groups. We also observed large differences in CFRs after
an acute cardiovascular event across both income level of
countries and education level, as well as the household
wealth of people within each country; however, details of
care during or immediately after an acute event were not
available.
The inverse gradient between low socioeconomic
status and cardiovascular disease in high-income
countries has been well documented.1–3,23,24 However,
although cardiovascular disease mortality has decreased
rapidly in high-income countries, low-income and
middle-income countries now face the greatest burden of
cardiovascular disease.25 Discussion of the changing
patterns in cardiovascular disease has been informed by
the concept of the epidemiological transition—the shift
from malnutrition and infectious diseases to degenerative
or non-communicable diseases, such as cardiovascular
disease, as major causes of death and disability, resulting
in an increasing average life expectancy and brought
about by industrialisation and urbanisation26,27—but what
is currently happening is unclear.7 Although there are
data on differences in risk factors by socioeconomic
status in low-income and middle-income countries, there
are sparse data on whether the incidence and mortality
after a cardiovascular disease event vary by socioeconomic
status in these countries.
In this study, education was the marker of socio
economic status that we found to be most clearly linked
with cardiovascular outcomes, consistent with our
previous report from the INTERHEART study.28 Low
education is a proxy for broader social disadvantage but
might directly impair an individual’s ability to obtain
effective care in several ways, including low awareness of
the importance of seeking timely care or reduced access
to information on how and where to obtain care and to
overcome barriers that exist, both through formal
channels and social networks. Lower education also
reduces life opportunities more generally, meaning that
individuals might not be able to afford necessary health
care or might live in neighbourhoods with worse access
to health-care facilities, especially in countries without
universal health coverage.29–31 These factors act through
out a person’s life. The effects of social and behavioural
factors are important, particularly where health-care
systems are unable to compensate for social and
economic disadvantages among the poor and less
educated. These factors are in line with our finding that,
in low-income countries, individuals with lower levels of
education with hypertension have a cumulative dis
advantage from detection to treatment and control, as
previously reported in Colombia.32 Consistent with this
finding, we also showed that those with the lowest levels
of education in low-income countries were disadvantaged
in access to primary and secondary prevention, and, as
previously noted, overall use of these medicines is also
www.thelancet.com/lancetgh Vol 7 June 2019
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alarmingly low in low-income and middle-income
countries.33 Given these findings, it is unsurprising that
we observed large differences by education in CFRs in
low-income countries. This finding is also consistent
with evidence from studies in India, where use of key
treatments (thrombolytics, β blockers, lipid-lowering
drugs, angiotensin-converting enzyme inhibitors or
angiotensin II receptor blockers, percutaneous coronary
intervention, and coronary artery bypass graft surgery) in
patients with acute myocardial infarction differed
substantially by socioeconomic status.34 Although the
mechanisms that cause inequalities in access to health
care might lead to differences in CFRs, the association
with differences in incidence of cardiovascular disease
might be less intuitive. However, we do know that most
of a sizeable proportion of those enrolled in PURE who
had either hypertension, diabetes, or cardiovascular
disease were either suboptimally treated or not treated at
all, particularly in low-income countries. Thus, there is
potential for preventing many events by improving the
use of simple proven treatments, especially in individuals
with a lower level of education.
In addition to differences in medical management,
other factors should be considered, because many people
will be healthy before an event and not in need of
medication. For example, differences in wealth might
affect an individual’s ability to afford a healthier diet if
certain components of a healthy diet, such as fruits and
vegetables, are relatively more expensive and thus
unaffordable to many, particularly in poorer countries.35
People with low levels of education in low-income and
middle-income countries had lower risk factor levels but a
higher risk of cardiovascular disease compared to those
with higher levels of education. This apparent paradox
could be due to epigenetics,36 or weight gain during critical
periods in childhood,37,38 adolescence, and adulthood,39 all
areas for which systematic information, especially from
middle-income and low-income countries, is lacking.
Other unmeasured factors might include working
conditions,40 other psychosocial stress factors,41 and
poverty in early life.42
The main strengths of our study are the inclusion of
many communities from several countries at different
economic levels, a standardised and systematic approach
to data collection, and use of both wealth and education
as markers of socioeconomic status. Limitations of our
study include grouping together of countries (within the
broad categories of low-income or high-income) that are
culturally and socially diverse, potentially also with
respect to quality of education—the quality of education
in low-income countries might be very different to that in
high-income countries. However, PURE, like most other
surveys on similar topics, did not collect data on the
quality of education. Thus, although partici
pants in
PURE are broadly similar to the populations of the
countries concerned,18 the effect of education and wealth
on health might vary between different countries within
www.thelancet.com/lancetgh Vol 7 June 2019

the same region. This could reflect the mediating effect of
welfare policies, or differences between ethnic groups,
where belief systems or social networks might confer
differing levels of resilience. For example, research in
Europe shows that the adverse health effects of un
employment differ among different models of the welfare
state,43 and the association between wealth and self-rated
health differs in ethnic groups in the USA.44 Furthermore,
the magnitude of ethnic differences in mortality in some
countries, including the USA, varies with independent
measures of racism45 and with measures of political
culture.46 However, disentangling these relationships is
extremely complicated in a multinational study because
of the very different national contexts.
Another limitation of this study is that the docu
mentation of cardiovascular events, which to a large
extent depended on admissions to hospital, might have
been less complete for people with scarce financial
resources. Therefore, event rates might have been even
higher in those with the lowest levels of education or
lowest wealth. However, it is possible that CFRs in lowincome and middle-income countries could have been
inflated if non-fatal events were incompletely reported.
Although we collected information from 20 countries,
the results might not necessarily be applicable to other
countries in the same income category that were not
included. Our study is not intended to be globally
representative, but instead the diversity of countries in
the study reflects the patterns of different associations
between socioeconomic status and risk factors,
treatments, and events. To our knowledge, PURE is the
largest prospective study to date with in-depth data on
socioeconomic status, risk factors, treatments, and fatal
and non-fatal events. Nevertheless, our findings might
not be applicable to some countries within a specific
economic category—for example, the USA—where the
social and health-care systems differ substantially from
other high-income countries. Our findings should
stimulate similar studies to PURE that involve additional
countries. However, our data show considerable
consistency in cardiovascular disease and mortality by
education group within each of the 20 countries, which
indicates our results are likely to be widely applicable.
In conclusion, cardiovascular disease in low-income
countries is a problem predominantly among people
with lower levels of education, whereas the situation in
middle-income countries is more variable. Despite a
lower risk factor burden among people with lower levels
of education in low-income countries, we found higher
rates of major cardiovascular disease. We observed
marked differences between those with the highest levels
of education and those with the lowest levels of education
in the treatment of hypertension and diabetes, secondary
prevention, and CFRs, as markers of substandard
management. Given the increasing prevalence of cardio
vascular disease, diabetes, and hypertension in lowincome and middle-income countries, these findings are
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important. The findings of this study emphasise the
importance of better education, which in turn can lead to
better care and more use of proven pharmacological
therapies. Therefore, measures to address the reasons
underlying why so many people struggle to obtain
education, and to assist them to remedy this situation,
are likely to mitigate some of the substantial excess
burden of cardiovascular disease and mortality, especially
among the least privileged in low-income countries.
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